- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Regentis Biomaterials Ltd (RGNT)
Regentis Biomaterials Ltd stock price live, this page displays NYSE RGNT stock exchange data. View the RGNT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Regentis Biomaterials Ltd real time stock price chart below.
What Is the Regentis Biomaterials Ltd Stock Price Today?
The Regentis Biomaterials Ltd stock price today is 1.89.
What Is the Stock Symbol for Regentis Biomaterials Ltd?
The stock symbol for Regentis Biomaterials Ltd is "RGNT."
What Stock Exchange Does Regentis Biomaterials Ltd Trade On?
Regentis Biomaterials Ltd is listed and trades on the NYSE stock exchange.
Is Regentis Biomaterials Ltd a Good Stock to Buy?
Determining whether Regentis Biomaterials Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGNT quote. (ISIN: IL0012190968)
What Is the Regentis Biomaterials Ltd Stock Price Today?
The Regentis Biomaterials Ltd stock price today is 1.89.
What Is the Stock Symbol for Regentis Biomaterials Ltd?
The stock symbol for Regentis Biomaterials Ltd is "RGNT."
What Stock Exchange Does Regentis Biomaterials Ltd Trade On?
Regentis Biomaterials Ltd is listed and trades on the NYSE stock exchange.
Is Regentis Biomaterials Ltd a Good Stock to Buy?
Determining whether Regentis Biomaterials Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGNT quote. (ISIN: IL0012190968)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.89
2.02
52 wk Range
1.23
15.50
RGNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.892.02
52 wk Range
1.2315.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RGNT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.00
Upside
+429.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 6K REGENTIS BIOMATERIALS LTD. For: 18 June- Investing.com
- Form 6K REGENTIS BIOMATERIALS LTD. For: 18 June
- Investing.com
Form 6K REGENTIS BIOMATERIALS LTD. For: 15 June- Investing.com
Form 6K REGENTIS BIOMATERIALS LTD. For: 8 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.00
(+429.10% Upside)
Earnings
Latest Release
Sep 11, 2026
EPS / Forecast
-0.22 / --
Revenue / Forecast
-- / --
Compare RGNT to Peers and Sector
Metrics to compare | RGNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRGNTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −1.8x | −0.4x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 1.3x | 2.2x | 2.6x | |
Price / LTM Sales | - | 9.6x | 3.0x | |
Upside (Analyst Target) | - | 1,049.1% | 55.1% | |
Fair Value Upside | Unlock | −8.0% | 8.2% | Unlock |
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Regentis Biomaterials (RGNT) Stock Price Today?
The Regentis Biomaterials stock price today is 1.89 USD.
What Stock Exchange Does Regentis Biomaterials Trade On?
Regentis Biomaterials is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Regentis Biomaterials?
The stock symbol for Regentis Biomaterials is "RGNT."
What Is the Regentis Biomaterials Market Cap?
As of today, Regentis Biomaterials market cap is 9.79M USD.
What Is Regentis Biomaterials's Earnings Per Share (TTM)?
The Regentis Biomaterials EPS (TTM) is -6.05.
From a Technical Analysis Perspective, Is RGNT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Regentis Biomaterials Stock Split?
Regentis Biomaterials has split 0 times.
What is the current trading status of Regentis Biomaterials (RGNT)?
As of Sep 13, 2026, Regentis Biomaterials (RGNT) is trading at a price of 1.89 USD, with a previous close of 1.96 USD. The stock has fluctuated within a day range of 1.89 USD to 2.02 USD, while its 52-week range spans from 1.23 USD to 15.50 USD.
What Is Regentis Biomaterials (RGNT) Price Target According to Analysts?
The average 12-month price target for Regentis Biomaterials is 10.00 USD, with a high estimate of 10 USD and a low estimate of 10 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +429.10% Upside potential.
What Is the RGNT Premarket Price?
RGNT's last pre-market stock price is 1.93 USD. The pre-market share volume is 1,340.00, and the stock has decreased by -0.03, or -1.53%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.